Quick Answer
ADAPTIN BIO, INC. reported Stockholders Equity of -$274.1 thousand for the year ending 2024.
- ADAPTIN BIO, INC. showed a decrease of -142.7% in Stockholders Equity from 2023 to 2024.
- This data is from ADAPTIN BIO, INC.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
- XBRL data for this metric is available from 2022 to 2024 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2022: -$14.6 thousand | Q2 2022: -$18.8 thousand | Q3 2022: -$23.1 thousand | Q1 2023: -$31.6 thousand | Q2 2023: -$35.8 thousand | Q3 2023: -$78.7 thousand | Q4 2023: -$977.6 thousand | Q1 2024: -$1.32 million | Q2 2024: -$2.14 million | Q3 2024: -$3.24 million | Q4 2024: -$4.10 million | Q1 2025: $1.75 million | Q2 2025: $474.4 thousand | Q3 2025: -$881.1 thousand.
- Over the full 3 years of available data (2022 to 2024), ADAPTIN BIO, INC.'s Stockholders Equity has declined by 903.7%.
- Historical annual values: Fiscal year 2024: -$274.1 thousand | Fiscal year 2023: -$112.9 thousand | Fiscal year 2022: -$27.3 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: